Munoz, M. (2026) “Aprepitant, When Used with Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients with Breast Cancer: Aprepitant in Breast Cancer Outcomes”, Pakistan Journal of Health Sciences. Pakistan, 7(8), pp. 01–02. doi: 10.54393/pjhs.v7i8.4537.